What is the outcome of hemophilia?

Hemophilia is an inherited bleeding disorder in which the blood does not clot properly. This can lead to spontaneous bleeding as well as prolonged bleeding following injuries or surgery. The condition predominantly affects males. Number and causes of death.

What is the process of hemophilia?

Hemophilia is caused by a mutation or change, in one of the genes, that provides instructions for making the clotting factor proteins needed to form a blood clot. This change or mutation can prevent the clotting protein from working properly or to be missing altogether. These genes are located on the X chromosome.

What happens to your body when you have hemophilia?

What is Hemophilia? Hemophilia is usually an inherited bleeding disorder in which the blood does not clot properly. This can lead to spontaneous bleeding as well as bleeding following injuries or surgery. Blood contains many proteins called clotting factors that can help to stop bleeding.

How is the prognosis of people with hemophilia improving?

Preventive measures and early treatment have significantly improved the long-term outlook, or prognosis, for people with severe hemophilia. Two major developments have led to people with hemophiliacs having better lives these days. One is clotting-promotion medicines known as antihemophilic factor concentrates, which prevent serious bleeding.

How are blood clotting factors related to hemophilia?

Blood contains many proteins called clotting factors that can help to stop bleeding. People with hemophilia have low levels of either factor VIII (8) or factor IX (9). The severity of hemophilia that a person has is determined by the amount of factor in the blood.

When does unprovoked bleeding occur in hemophilia?

In severe hemophilia, unprovoked (spontaneous) bleeding episodes occur often. In moderate hemophilia, prolonged bleeding tends to occur after a more significant injury. In mild hemophilia, a patient might have unusual bleeding, but only after a major injury, surgery, or trauma.

What is Hemophilia? Hemophilia is usually an inherited bleeding disorder in which the blood does not clot properly. This can lead to spontaneous bleeding as well as bleeding following injuries or surgery. Blood contains many proteins called clotting factors that can help to stop bleeding.

Preventive measures and early treatment have significantly improved the long-term outlook, or prognosis, for people with severe hemophilia. Two major developments have led to people with hemophiliacs having better lives these days. One is clotting-promotion medicines known as antihemophilic factor concentrates, which prevent serious bleeding.

In severe hemophilia, unprovoked (spontaneous) bleeding episodes occur often. In moderate hemophilia, prolonged bleeding tends to occur after a more significant injury. In mild hemophilia, a patient might have unusual bleeding, but only after a major injury, surgery, or trauma.

How are blood clotting factors replaced in hemophilia?

Treatment depends on the type and severity of the disorder. It consists of replacement therapy, in which human plasma concentrates or recombinant (produced from DNA) forms of the clotting factors VIII or IX are given to replace the blood clotting factors that are missing or deficient.